A decreased expression of hemeoxygenase-1 (HO-1), a proangiogenic antioxidant enzyme, was reported in transforming growth factor (TGF)-β-treated SSc fibroblasts and HUVECs [35]. This evidence concerns the gene TGFB1 and systemic sclerosis.